Clinical Trial Update: Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS) [Phase 4]

View source ↗

Summary

Phase 4 long-term study of pramipexole in idiopathic moderate-to-severe restless legs syndrome shows sustained efficacy and acceptable safety/tolerability over …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Pramipexole (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Restless Legs Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2009-11-17